After Dow Chemical reported higher than expected EPS but the stock fell, RBC Capital says that the decline was driven by macro concerns. However, the firm remains upbeat on the stock's outlook, partly due to the company's low exposure to NGL, what it estimates will be a 20% increase in EBITDA growth through 2019 due to new projects, and spending cuts. RBC keeps a $62 price target and Outperform rating.
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1... To see the rest of the story go to thefly.com. See Story Here